By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Contact Information

Website: www.uniqure.com
Email: M.Cantor@uniQure.com
Main Phone: +31 202406000
Address: Paasheuvelweg 25a
State: NH
City / Town: Amsterdam
Country: NL
Postal Code: 1105 BP

Issuer Information

Exchange: NGS
CEO: Matthew C. Kapusta
Employees: 332

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A